Additionally, astilbin may demonstrate satisfactory efficacy against RA by activating the A2AAR/adenosine system and inhibiting ERK/nuclear factor-kappa B (NF-kB)/STAT signalling pathways (26). The gene discussed is NFKB1; the disease is rheumatoid arthritis.